Organigram Holdings | OGI - Sales Revenues



Organigram Holdings reported CAD70.79M in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
Acasti Pharma USD -4760000 4.76M Dec/2024
Alaunos Therapeutics USD 0 4K Sep/2024
Aurora Cannabis CAD 98.02M 9.82M Jun/2025
Avita Medical AUD 18.41M 7.89M Dec/2024
Canopy Growth CAD 72.13M 2.63M Jun/2025
Cronos Group USD 33.46M 160K Jun/2025
Dianthus Therapeutics USD 193K 1.13M Jun/2025
Ionis Pharmaceuticals USD 452M 320M Jun/2025
IQVIA Holdings USD 4.02B 190M Jun/2025
Knight Therapeutics CAD 92.26M 3.31M Sep/2024
Moderna USD 142M 34M Jun/2025
Organigram Holdings CAD 70.79M 28.06M Jun/2025
Organon & Co 1.59B 80M Jun/2025
Revvity USD 720M 55M Jun/2025
Tectonic Therapeutic 0 0 Dec/2024
Tilray USD 308.01M 43.78M Jun/2025
Viatris USD 3.57B 320M Jun/2025
Xeris Pharmaceuticals USD 71.54M 11.44M Jun/2025